Building Continuous & Modular mRNA Manufacturing Platforms to Improve Flexibility, Contamination Control & Cost Efficiency
2:00 pm - Friday 19th February 2027
- Using closed systems to reduce contamination risk and manual intervention
- Building modular IVT, purification and LNP manufacturing operations that can flex between products and scales
- Standardising equipment and process controls to simplify transfer between manufacturing sites
- Understanding where modular manufacturing genuinely improves cost, speed and flexibility versus traditional fixed facilities
